Skip to content

Farmaking OÜ

Registry code (registrikood) 14825023Private limited company (Osaühing)VAT EE102200643Activity (EMTAK 47731): Ravimite jaemüükActive

Maardu linn, Harju County · Financial data: annual reports up to 2025; tax data up to 2026 Q3

Revenue (2025)
€2.8M
▲ 30.6% vs 2024
Profit before tax (2025)
€85k
Employees, FTE (2025)
8
State taxes paid, last 4 quarters
€348k

Revenue, profit and employees, 2020–2025

€932k2020€1.4M2021€1.4M2022€1.6M2023€2.2M2024€2.8M2025
YearRevenue (müügitulu)Operating profit (ärikasum)Net profitEquity (omakapital)Employees, FTE
2020€932,082€1,712€1,712€1,7128
2021€1,437,887-€5,358-€5,358-€3,6467
2022€1,391,075€13,671€13,671€10,0255
2023€1,564,708-€18,659-€18,659-€8,6347
2024€2,155,738-€14,647-€14,646-€23,2807
2025€2,814,570€85,122€85,133€61,8538

Balance sheet summary

YearCashTotal assetsCurrent liabilitiesNon-current liabilitiesEquity
2020€28,569€514,848€513,136—€1,712
2021€13,031€328,045€331,691—-€3,646
2022€13,419€375,363€365,338—€10,025
2023€19,326€407,686€416,320—-€8,634
2024€21,995€453,059€476,339—-€23,280
2025€58,376€820,452€758,599—€61,853

Calculated ratios

Net profit margin = net profit ÷ revenue. Equity ratio = equity ÷ total assets. Seedata sources & methodology for how each figure is derived.

Quarterly tax and turnover data (EMTA)

QuarterState taxes paidWage taxesTurnoverEmployees
2022 Q1€24,666€19,031€384,59614
2022 Q2€25,178€20,520€392,36014
2022 Q3€25,155€21,586€341,07713
2022 Q4€26,036€20,941€401,37312
2023 Q1€35,786€21,000€447,66612
2023 Q2€21,923€20,429€383,59012
2023 Q3€23,947€21,267€383,51512
2023 Q4€34,091€22,360€516,12214
2024 Q1€36,664€32,431€567,09114
2024 Q2€40,187€32,631€586,93615
2024 Q3€37,312€31,671€537,93515
2024 Q4€35,424€30,751€625,18817
2025 Q1€45,903€31,203€575,57617
2025 Q2€34,485€25,596€547,47121
2025 Q3€49,676€34,241€586,07321
2025 Q4€58,369€48,795€1,108,10124
2026 Q1€104,849€85,383€1,415,91226
2026 Q2€92,219€77,296€1,274,69925
2026 Q3€92,109€76,017€1,186,70326

Source: EMTA quarterly published data, as of 10 October 2026. Covers state taxes and wage taxes actually paid and turnover and employee counts as declared by the company, not the annual report figures above.

About this data

In the 2025 financial year (period 1 January 2025–31 December 2025), Farmaking OÜ reported revenue of €2,814,570.

The company closed the 2025 financial year with a net profit of €85,133.

Revenue increased by 30.6% from €2,155,738 in 2024 to €2,814,570 in 2025.

Revenue grew at a compound annual rate of 24.7% between 2020 and 2025.

Equity accounted for 7.5% of total assets of €820,452 at the end of the 2025 reporting period.

With 8 full-time-equivalent employees in 2025, revenue per employee was €351,821.

Across the 4 most recent quarters declared to EMTA, up to Q3 2026, Farmaking OÜ reported €4,985,415 in turnover.

EMTA recorded 26 employees for the quarter ending Q3 2026, compared with 8 full-time-equivalent employees in the 2025 annual report.

Browse

Source

Source: Estonian e-Business Register open data (Centre of Registers and Information Systems, RIK), licence CC BY-SA 4.0, modified; Estonian Tax and Customs Board (EMTA) quarterly data. Downloaded 2026-11-16. This is not an official register extract — see ariregister.rik.ee.

Company data on this site is available under CC BY-SA 4.0.

To request a correction or the removal of this page, use the contact form. Removal requests are handled within 30 days, no justification required.